24.255 gm/50 mL (485.1 mg/mL), 7.2765 gm/15 mL (485.1 mg/mL), 3.63825 gm/7.5 mL (485.1 mg/mL), 48.51 gm/100 mL (485.1 mg/mL), 14.553 gm/30 mL (485.1 mg/mL), 4.851 gm/10 mL (485.1 mg/mL), 1.4553 gm/3 mL (485.1 mg/mL)
Therapeutic Category
Diagnostic agent
Usage
To detect and visualize lesions, together with MRI, with abnormal vascularity in the central nervous system and the body
Good to know
Frequently asked questions
Why Spring Bio Solution
Intelligence you can file on
Verified regulatory data
Milestones tracked against primary FDA sources and refreshed continuously.
Analyst-built projections
Seven-year sales outlooks modeled by our pharma intelligence team.
First-to-file focus
Exclusivity windows framed around the decisions generics teams actually make.
Partnership on demand
From API sourcing to dossier support — one request starts the conversation.
Ready to act on this opportunity?
Talk to Spring Bio Solution about sourcing, licensing, and filing support for this molecule.
